HETEROGENEITY AMONG HUMAN CD4+ T-CELL CLONES

人类 CD4 T 细胞克隆的异质性

• 批准号: 7375185
• 负责人: RICHARD Barry MOSS
• 金额: $ 0.31万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375185
• 关键词: HETEROGENEITY; AMONG; HUMAN; CD4+; CELL

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of these studies is to understand the immunobiology of asthma and allergic diseases. We will identify and examine mechanisms that down-modulate allergic immune responses in humans, and determine the cell types and molecules that participate in the protection against allergic inflammation. These studies involve using MCH class II-peptide tetramers and cDNA microarrays. In the near future, some subjects will be treated with allergen immunotherapy and the changes in immune responses will be monitored. In other studies, we are attempting to identify genes and their polymorphisms that are involved in causing allergy and asthma.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这些研究的目的是了解哮喘和过敏性疾病的免疫生物学。我们将鉴定和研究下调人类过敏性免疫反应的机制，并确定参与保护免受过敏性炎症的细胞类型和分子。这些研究涉及使用MCH II类肽四聚体和cDNA微阵列。在不久的将来，一些受试者将接受过敏原免疫治疗，并监测免疫反应的变化。在其他的研究中，我们正试图确定与引起过敏和哮喘有关的基因及其多态性。